ConductScience.org, home

Paper33170686

Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design.

Alleyne C and 28 others. J Med Chem, 2020. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design. Papers, record 33170686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33170686

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design.
PubMed
Journal
J Med Chem
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
4.89
iCite
Revised in PubMed
2021-12-04
PubMed

Authors29

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alleyne CCandice
2Amin RPRupesh P
3Bhatt BBhavana
4Bianchi EElisabetta
5Blain JCJ Craig
6Boyer NNicolas
7Branca DDanila
8Embrey MWMark W
9Ha SNSookhee N
10Jette KKelli
11Johns DGDouglas G
12Kerekes ADAngela D
13Koeplinger KAKenneth A
14LaPlaca DDerekhttps://orcid.org/0000-0002-8513-2445
15Li NNianyu
16Murphy BBeth
17Orth PPeter
18Ricardo AAlonso
19Salowe SScott
20Seyb KKathleen

Source PubMed

See all 29 authorsDownload CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug DesignMajor topic
Enzyme InhibitorsMajor topic
PCSK9 InhibitorsMajor topic
Proprotein Convertase 9Major topic
RNA, MessengerMajor topic
Animals
Cells, Cultured
Crystallography, X-Ray
Female
Humans
Macaca fascicularis
Male
Mice
Mice, Inbred C57BL
Protein Structure, Secondary
Protein Structure, Tertiary
Rats
Rats, Wistar
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
42812996Advancing Drug Discovery through Academia-Industry Collaborations: Lessons from Merck Discovery Chemistry Partnerships.ACS Cent Sci2026https://conductscience.org/library/papers/42812996PubMed
42446232Hybrid Macrocyclic Peptides - Synthetic Strategies to Diversify and Cyclize Peptide Libraries in Phage Display Selections.Chemistry2026https://conductscience.org/library/papers/42446232PubMed
42189178The evolving role of structural biology in pharma: integration of X-ray crystallography, cryo-electron microscopy and beyond.Acta Crystallogr D Struct Biol2026https://conductscience.org/library/papers/42189178PubMed
41963347Massive barcode-free chemical screenings enable the discovery of bioactive macrocycles with passive membrane permeability.Nat Commun2026https://conductscience.org/library/papers/41963347PubMed
41890397Efficient Synthesis of Enlicitide Chloride through Convergent Solution-Phase and Hybrid Solution-Solid-Phase Strategies.Precis Chem2026https://conductscience.org/library/papers/41890397PubMed
41645422StrEAMM-Thioether: Efficient Structure Prediction for Thioether-Linked Cyclic Peptides.J Phys Chem B2026https://conductscience.org/library/papers/41645422PubMed
41561465Which halogen to choose? Comparing the effects of chlorine and fluorine as bioisosteric substituents in drug design.Chem Sci2026https://conductscience.org/library/papers/41561465PubMed
41478627PCSK9 inhibitors: a promising lipid-lowering strategy for kidney transplant recipients.Ren Fail2025https://conductscience.org/library/papers/41478627PubMed
41379101Discovery of Zilucoplan: A Complement C5 Inhibitor for Treatment of Anti-Acetylcholine Receptor (AChR) Antibody-Positive Generalized Myasthenia Gravis (gMG).J Med Chem2025https://conductscience.org/library/papers/41379101PubMed
41188059De Novo Discovery of α,α-Disubstituted α-amino Acid-Containing α-helical Peptides as Competitive PPARγ PPI Inhibitors.J Am Chem Soc2025https://conductscience.org/library/papers/41188059PubMed
41158548Chemoselective sulfonyl fluoride exchange (SuFEx)-induced macrocyclization of tyrosine-containing peptides in aqueous media.Chem Sci2025https://conductscience.org/library/papers/41158548PubMed
41157908Chemokine-Binding All-D-CLIPS Peptides Identified Using Mirror-Image Phage Display.ACS Chem Biol2025https://conductscience.org/library/papers/41157908PubMed
40893970Targeted Protein Modification with an Antibody-Based System.ACS Cent Sci2025https://conductscience.org/library/papers/40893970PubMed
40531458Tips and Tricks in Reversed-Phase Flash Chromatography for Peptide Purification.Methods Mol Biol2025https://conductscience.org/library/papers/40531458PubMed
40168664From Cortisone to Enlicitide: A Journey of Synthetic Chemistry Innovations at Merck.J Org Chem2025https://conductscience.org/library/papers/40168664PubMed
39776654Late-stage installation and functionalization of alkyl pyridiniums: a general HTE amenable strategy to access diverse aryl alanine containing macrocyclic peptides.Chem Sci2025https://conductscience.org/library/papers/39776654PubMed
39702664Discovering covalent cyclic peptide inhibitors of peptidyl arginine deiminase 4 (PADI4) using mRNA-display with a genetically encoded electrophilic warhead.Commun Chem2024https://conductscience.org/library/papers/39702664PubMed
39540650Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics.Chem Rev2024https://conductscience.org/library/papers/39540650PubMed
39463829Activity-Based DNA-Encoded Library Screening for Selective Inhibitors of Eukaryotic Translation.ACS Cent Sci2024https://conductscience.org/library/papers/39463829PubMed
39418482Reaching New Heights in Genetic Code Manipulation with High Throughput Screening.Chem Rev2024https://conductscience.org/library/papers/39418482PubMed

See all 39 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
LDLR3949PubTator's text mininghttps://conductscience.org/library/genes/3949NCBI Gene
PCSK9255738PubTator's text mininghttps://conductscience.org/library/genes/255738NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33170686

GET https://conductscience.org/api/papers/v1/33170686/authors?page=2